Greatly Transformed Sinovac Set to Reawaken on Wall Street? 重大調整後的科興生物將在華爾街重新崛起？
Company’s third-quarter revenue was significantly lower than guidance given three months earlier, as it cited delays in several project sales. 經過將近三年的停盤，在出現了兩項重大法律進展後，這個新冠疫苗生產商有望很快在那斯達克恢復交易。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.